BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 25304676)

  • 1. Uterine leiomyosarcoma: a review article.
    Gockley AA; Rauh-Hain JA; del Carmen MG
    Int J Gynecol Cancer; 2014 Nov; 24(9):1538-42. PubMed ID: 25304676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimal management of uterine leiomyosarcoma.
    O'Cearbhaill R; Hensley ML
    Expert Rev Anticancer Ther; 2010 Feb; 10(2):153-69. PubMed ID: 20131992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uterine leiomyosarcoma: A review of the literature and update on management options.
    Roberts ME; Aynardi JT; Chu CS
    Gynecol Oncol; 2018 Dec; 151(3):562-572. PubMed ID: 30244960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Uterine leiomyosarcoma: present management.
    Giuntoli RL; Bristow RE
    Curr Opin Oncol; 2004 Jul; 16(4):324-7. PubMed ID: 15187886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Options for Adjuvant Therapy for Uterine Leiomyosarcoma.
    Friedman CF; Hensley ML
    Curr Treat Options Oncol; 2018 Feb; 19(2):7. PubMed ID: 29417238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Low-grade leiomyosarcoma" and late-recurring smooth muscle tumors of the uterus: a heterogenous collection of frequently misdiagnosed tumors associated with an overall favorable prognosis relative to conventional uterine leiomyosarcomas.
    Veras E; Zivanovic O; Jacks L; Chiappetta D; Hensley M; Soslow R
    Am J Surg Pathol; 2011 Nov; 35(11):1626-37. PubMed ID: 21921786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of uterine leiomyosarcoma. Results from a 10-year experience (1990-1999) at the Massachusetts General Hospital.
    Dinh TA; Oliva EA; Fuller AF; Lee H; Goodman A
    Gynecol Oncol; 2004 Feb; 92(2):648-52. PubMed ID: 14766261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Avoiding treatment of leiomyosarcomas: the role of magnetic resonance in focused ultrasound surgery.
    Samuel A; Fennessy FM; Tempany CM; Stewart EA
    Fertil Steril; 2008 Sep; 90(3):850.e9-12. PubMed ID: 18022163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Literature review of outcomes and prevalence and case report of leiomyosarcomas and non-typical uterine smooth muscle leiomyoma tumors treated with uterine artery embolization.
    Kainsbak J; Hansen ES; Dueholm M
    Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():130-7. PubMed ID: 26117442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A reassessment of uterine neoplasms originally diagnosed as leiomyosarcomas.
    Hart WR; Billman JK
    Cancer; 1978 May; 41(5):1902-10. PubMed ID: 647634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian and uterine leiomyosarcoma: which one is the primary?
    Shafiee MN; Kah Teik C; Md Zain RR; Kampan N
    Horm Mol Biol Clin Investig; 2019 Aug; 41(2):. PubMed ID: 31398145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of adjuvant therapy in uterine leiomyosarcoma.
    Ducie JA; Leitao MM
    Expert Rev Anticancer Ther; 2016; 16(1):45-55. PubMed ID: 26558647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uterine Leiomyosarcoma.
    Juhasz-Böss I; Gabriel L; Bohle RM; Horn LC; Solomayer EF; Breitbach GP
    Oncol Res Treat; 2018; 41(11):680-686. PubMed ID: 30321869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and treatment of uterine leiomyosarcoma: A National Cancer Database study.
    Seagle BL; Sobecki-Rausch J; Strohl AE; Shilpi A; Grace A; Shahabi S
    Gynecol Oncol; 2017 Apr; 145(1):61-70. PubMed ID: 28317559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uterine leiomyosarcoma: a rare clinical entity.
    Dunphy L; Sheridan G
    BMJ Case Rep; 2021 Aug; 14(8):. PubMed ID: 34433536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of advanced uterine leiomyosarcoma.
    Hyman DM; Grisham RN; Hensley ML
    Curr Opin Oncol; 2014 Jul; 26(4):422-7. PubMed ID: 24840518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in the treatment of uterine leiomyosarcoma in the Medicare population.
    Foley OW; Rauh-Hain JA; Clemmer J; Clark RM; Hall T; Diver EJ; Schorge JO; del Carmen MG
    Int J Gynecol Cancer; 2015 Mar; 25(3):453-8. PubMed ID: 25628107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine leiomyosarcoma: a review of recent advances in molecular biology, clinical management and outcome.
    Cui RR; Wright JD; Hou JY
    BJOG; 2017 Jun; 124(7):1028-1037. PubMed ID: 28128524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 receptor expression in patients with uterine smooth muscle tumors: an immunohistochemical analysis comparing leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma.
    Bodner K; Bodner-Adler B; Kimberger O; Czerwenka K; Mayerhofer K
    J Soc Gynecol Investig; 2004 Apr; 11(3):187-91. PubMed ID: 15051039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uterine leiomyosarcoma metastatic to the sphenoid sinus: a case report and review of the literature.
    Sandruck J; Escobar P; Lurain J; Fishman D
    Gynecol Oncol; 2004 Feb; 92(2):701-4. PubMed ID: 14766270
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.